Outpatient vs inpatient induction of labor with oral misoprostol: A retrospective study
- PMID: 36965000
- PMCID: PMC10072241
- DOI: 10.1111/aogs.14550
Outpatient vs inpatient induction of labor with oral misoprostol: A retrospective study
Abstract
Introduction: Induction of labor is one of the most common obstetrical procedures today, with a successively rising rate. With a limited number of hospital beds, the option of starting induction at home has gained increasing attention. The primary aim of this study was to compare the proportion of women achieving vaginal delivery and the duration of hospital stay before delivery in induction of labor with oral misoprostol starting at home and induction with oral misoprostol at the hospital, in a low-risk population.
Material and methods: Women with home induction (n = 282) were individually matched to controls induced at the hospital during the same time period regarding parity, age, body mass index, labor unit and indication for induction.
Results: The rates of vaginal birth were similar in outpatients and inpatients (84.8% vs 86.2%; p = 0.5). Time from hospital admission to delivery in the outpatient group was significantly shorter than in the inpatient group (12.8 vs 20.6 h; p < 0.001), as was total hospital stay (2 vs 3 days; p < 0.001). There were no significant differences between the groups in neonatal or maternal outcomes. One patient undergoing outpatient induction had an unplanned home birth.
Conclusions: Starting induction at home reduced the time spent in hospital without affecting the vaginal delivery rate. Although underpowered to assess safety, this study did not show any differences in adverse maternal and perinatal outcomes between inpatients and outpatients. Further research is needed to evaluate the safety of outpatient induction of labor with misoprostol.
Keywords: cervical ripening; misoprostol; outpatient induction of labor; prostaglandins.
© 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
Conflict of interest statement
The authors have stated explicitly that there are no conflicts of interest in connection with this article.
Similar articles
-
Labor Induction Outcomes with Outpatient Misoprostol for Cervical Ripening among Low-Risk Women.Am J Perinatol. 2024 May;41(S 01):e818-e826. doi: 10.1055/a-1948-2779. Epub 2022 Sep 21. Am J Perinatol. 2024. PMID: 36130669
-
Cervical ripening as an outpatient procedure in the pandemic - minimizing the inpatient days and lowering the socioeconomic costs.J Perinat Med. 2022 Aug 9;50(9):1180-1188. doi: 10.1515/jpm-2022-0196. Print 2022 Nov 25. J Perinat Med. 2022. PMID: 35942570
-
Vaginal misoprostol for cervical ripening at term: comparison of outpatient vs. inpatient administration.J Reprod Med. 2005 Oct;50(10):735-9. J Reprod Med. 2005. PMID: 16320553
-
Misoprostol vaginal insert for induction of labor: a delivery system with accurate dosing and rapid discontinuation.Womens Health (Lond). 2014 Jan;10(1):29-36. doi: 10.2217/whe.13.49. Womens Health (Lond). 2014. PMID: 24328596 Review.
-
A novel misoprostol delivery system for induction of labor: clinical utility and patient considerations.Drug Des Devel Ther. 2015 Apr 22;9:2321-7. doi: 10.2147/DDDT.S64227. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25960635 Free PMC article. Review.
Cited by
-
Outcomes of Outpatient Versus Inpatient Induction of Labor: A Systematic Review and Meta-Analysis.Cureus. 2024 Sep 16;16(9):e69535. doi: 10.7759/cureus.69535. eCollection 2024 Sep. Cureus. 2024. PMID: 39286471 Free PMC article. Review.
-
Comparison of Modified Labor Induction Strategies for Pregnant Women at a Single Tertiary Center Before and During the COVID-19 Pandemic.Diagnostics (Basel). 2024 Dec 5;14(23):2739. doi: 10.3390/diagnostics14232739. Diagnostics (Basel). 2024. PMID: 39682647 Free PMC article.
-
Outpatient labor induction-Exploring future potential by assessing eligibility in a historical cohort.Acta Obstet Gynecol Scand. 2024 Jun;103(6):1101-1111. doi: 10.1111/aogs.14799. Epub 2024 Mar 19. Acta Obstet Gynecol Scand. 2024. PMID: 38504457 Free PMC article.
-
Clinical outcomes and feasibility of implementing outpatient labor induction with misoprostol: A prospective cohort study.Acta Obstet Gynecol Scand. 2025 Apr;104(4):647-657. doi: 10.1111/aogs.15029. Epub 2025 Jan 29. Acta Obstet Gynecol Scand. 2025. PMID: 39878306 Free PMC article.
References
-
- Socialstyrelsen . Graviditeter, förlossningar och nyfödda barn [Pregnancies, deliveries and newborns]. Medicinska födelseregistret. Stockholm. 2020.
-
- ten Eikelder MLG, Oude Rengerink K, Jozwiak M, et al. Induction of labour at term with oral misoprostol versus a Foley catheter (PROBAAT‐II): a multicentre randomised controlled non‐inferiority trial. Lancet. 2016;387:1619‐1628. - PubMed
-
- Bendix JM, Friis Petersen J, Andersen BR, Bodker B, Lokkegaard EC. Induction of labor with high‐ or low‐dosage oral misoprostol‐a Danish descriptive retrospective cohort study 2015‐16. Acta Obstet Gynecol Scand. 2020;99:222‐230. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources